Gossamer Bio, Inc. (GOSS)
0.4684
+0.04
(+9.29%)
USD |
NASDAQ |
Mar 03, 16:00
0.4709
0.00 (0.00%)
After-Hours: 18:04
Gossamer Bio Cash from Investing (TTM) : 136.42M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 94.86M |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| XOMA Royalty Corp. | -4.892M |
| Rezolute, Inc. | -22.28M |
| Axsome Therapeutics, Inc. | -0.48M |